866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Oncology Injection Drug Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 118 Pages

In this report, the EMEA Oncology Injection Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oncology Injection Drug for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oncology Injection Drug market competition by top manufacturers/players, with Oncology Injection Drug sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Organs
Central Nervous System
Circulatory/Musculoskeletal System

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oncology Injection Drug for each application, including
Lymphoma
Myeloma
Prostate Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Oncology Injection Drug Market Report 2017
1 Oncology Injection Drug Overview
1.1 Product Overview and Scope of Oncology Injection Drug
1.2 Classification of Oncology Injection Drug
1.2.1 EMEA Oncology Injection Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oncology Injection Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Organs
1.2.4 Central Nervous System
1.2.5 Circulatory/Musculoskeletal System
1.3 EMEA Oncology Injection Drug Market by Application/End Users
1.3.1 EMEA Oncology Injection Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.4 EMEA Oncology Injection Drug Market by Region
1.4.1 EMEA Oncology Injection Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oncology Injection Drug (2012-2022)
1.5.1 EMEA Oncology Injection Drug Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oncology Injection Drug Revenue and Growth Rate (2012-2022)

2 EMEA Oncology Injection Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Oncology Injection Drug Market Competition by Players/Manufacturers
2.1.1 EMEA Oncology Injection Drug Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Oncology Injection Drug Revenue and Share by Players (2012-2017)
2.1.3 EMEA Oncology Injection Drug Sale Price by Players (2012-2017)
2.2 EMEA Oncology Injection Drug (Volume and Value) by Type/Product Category
2.2.1 EMEA Oncology Injection Drug Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Oncology Injection Drug Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Oncology Injection Drug Sale Price by Type (2012-2017)
2.3 EMEA Oncology Injection Drug (Volume) by Application
2.4 EMEA Oncology Injection Drug (Volume and Value) by Region
2.4.1 EMEA Oncology Injection Drug Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Oncology Injection Drug Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Oncology Injection Drug Sales Price by Region (2012-2017)

3 Europe Oncology Injection Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Oncology Injection Drug Sales and Value (2012-2017)
3.1.1 Europe Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Oncology Injection Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Oncology Injection Drug Sales and Market Share by Type
3.3 Europe Oncology Injection Drug Sales and Market Share by Application
3.4 Europe Oncology Injection Drug Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oncology Injection Drug Sales Volume by Countries (2012-2017)
3.4.2 Europe Oncology Injection Drug Revenue by Countries (2012-2017)
3.4.3 Germany Oncology Injection Drug Sales and Growth Rate (2012-2017)
3.4.4 France Oncology Injection Drug Sales and Growth Rate (2012-2017)
3.4.5 UK Oncology Injection Drug Sales and Growth Rate (2012-2017)
3.4.6 Russia Oncology Injection Drug Sales and Growth Rate (2012-2017)
3.4.7 Italy Oncology Injection Drug Sales and Growth Rate (2012-2017)
3.4.8 Benelux Oncology Injection Drug Sales and Growth Rate (2012-2017)

4 Middle East Oncology Injection Drug (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Oncology Injection Drug Sales and Value (2012-2017)
4.1.1 Middle East Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Oncology Injection Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Oncology Injection Drug Sales and Market Share by Type
4.3 Middle East Oncology Injection Drug Sales and Market Share by Application
4.4 Middle East Oncology Injection Drug Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oncology Injection Drug Sales Volume by Countries (2012-2017)
4.4.2 Middle East Oncology Injection Drug Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2012-2017)
4.4.4 Israel Oncology Injection Drug Sales and Growth Rate (2012-2017)
4.4.5 UAE Oncology Injection Drug Sales and Growth Rate (2012-2017)
4.4.6 Iran Oncology Injection Drug Sales and Growth Rate (2012-2017)

5 Africa Oncology Injection Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Oncology Injection Drug Sales and Value (2012-2017)
5.1.1 Africa Oncology Injection Drug Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Oncology Injection Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Oncology Injection Drug Sales and Market Share by Type
5.3 Africa Oncology Injection Drug Sales and Market Share by Application
5.4 Africa Oncology Injection Drug Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oncology Injection Drug Sales Volume by Countries (2012-2017)
5.4.2 Africa Oncology Injection Drug Revenue by Countries (2012-2017)
5.4.3 South Africa Oncology Injection Drug Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Oncology Injection Drug Sales and Growth Rate (2012-2017)
5.4.5 Egypt Oncology Injection Drug Sales and Growth Rate (2012-2017)
5.4.6 Algeria Oncology Injection Drug Sales and Growth Rate (2012-2017)

6 EMEA Oncology Injection Drug Manufacturers/Players Profiles and Sales Data
6.1 Taj Oncology
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oncology Injection Drug Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 S.G. Biopharm
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oncology Injection Drug Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 AdvaCare
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oncology Injection Drug Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merrimack
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oncology Injection Drug Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Celgene
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oncology Injection Drug Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Allos Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oncology Injection Drug Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Ferring Pharmaceuticals
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oncology Injection Drug Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Genzyme
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oncology Injection Drug Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oncology Injection Drug Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Praecis Pharmaceuticals
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oncology Injection Drug Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Millennium Pharmaceuticals
6.12 Debiopharm
6.13 Alza
6.14 CordenPharma
6.15 Pharmascience

7 Oncology Injection Drug Manufacturing Cost Analysis
7.1 Oncology Injection Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Injection Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncology Injection Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Injection Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Oncology Injection Drug Market Forecast (2017-2022)
11.1 EMEA Oncology Injection Drug Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Oncology Injection Drug Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Oncology Injection Drug Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Oncology Injection Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Oncology Injection Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oncology Injection Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oncology Injection Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oncology Injection Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oncology Injection Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Oncology Injection Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Oncology Injection Drug
Figure EMEA Oncology Injection Drug Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oncology Injection Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Organs Product Picture
Figure Central Nervous System Product Picture
Figure Circulatory/Musculoskeletal System Product Picture
Figure EMEA Oncology Injection Drug Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oncology Injection Drug by Application in 2016
Figure Lymphoma Examples
Figure Myeloma Examples
Figure Prostate Cancer Examples
Figure EMEA Oncology Injection Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oncology Injection Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oncology Injection Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oncology Injection Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oncology Injection Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oncology Injection Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oncology Injection Drug Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oncology Injection Drug Sales Share by Players (2012-2017)
Figure 2016 Oncology Injection Drug Sales Share by Players
Figure 2017 Oncology Injection Drug Sales Share by Players
Figure EMEA Oncology Injection Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oncology Injection Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Oncology Injection Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Oncology Injection Drug Revenue Share by Players
Table 2017 EMEA Oncology Injection Drug Revenue Share by Players
Table EMEA Oncology Injection Drug Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oncology Injection Drug Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oncology Injection Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Oncology Injection Drug by Type (2012-2017)
Figure EMEA Oncology Injection Drug Sales Market Share by Type (2012-2017)
Table EMEA Oncology Injection Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oncology Injection Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Injection Drug by Type in 2016
Table EMEA Oncology Injection Drug Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oncology Injection Drug Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oncology Injection Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Oncology Injection Drug by Application (2012-2017)
Figure EMEA Oncology Injection Drug Sales Market Share by Application in 2016
Table EMEA Oncology Injection Drug Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oncology Injection Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Oncology Injection Drug by Region (2012-2017)
Figure EMEA Oncology Injection Drug Sales Market Share in 2016
Table EMEA Oncology Injection Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oncology Injection Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oncology Injection Drug by Region (2012-2017)
Figure EMEA Oncology Injection Drug Revenue Market Share Regions in 2016
Table EMEA Oncology Injection Drug Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oncology Injection Drug Revenue and Growth Rate (2012-2017)
Table Europe Oncology Injection Drug Sales (K Units) by Type (2012-2017)
Table Europe Oncology Injection Drug Market Share by Type (2012-2017)
Figure Europe Oncology Injection Drug Market Share by Type in 2016
Table Europe Oncology Injection Drug Sales (K Units) by Application (2012-2017)
Table Europe Oncology Injection Drug Market Share by Application (2012-2017)
Figure Europe Oncology Injection Drug Market Share by Application in 2016
Table Europe Oncology Injection Drug Sales (K Units) by Countries (2012-2017)
Table Europe Oncology Injection Drug Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Injection Drug Sales Market Share by Countries (2012-2017)
Figure Europe Oncology Injection Drug Sales Market Share by Countries in 2016
Table Europe Oncology Injection Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Oncology Injection Drug Revenue Market Share by Countries in 2016
Figure Germany Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure France Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oncology Injection Drug Sales (K Units) by Type (2012-2017)
Table Middle East Oncology Injection Drug Market Share by Type (2012-2017)
Figure Middle East Oncology Injection Drug Market Share by Type (2012-2017)
Table Middle East Oncology Injection Drug Sales (K Units) by Applications (2012-2017)
Table Middle East Oncology Injection Drug Market Share by Applications (2012-2017)
Figure Middle East Oncology Injection Drug Sales Market Share by Application in 2016
Table Middle East Oncology Injection Drug Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oncology Injection Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oncology Injection Drug Sales Volume Market Share by Countries in 2016
Table Middle East Oncology Injection Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Oncology Injection Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oncology Injection Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oncology Injection Drug Sales (K Units) by Type (2012-2017)
Table Africa Oncology Injection Drug Sales Market Share by Type (2012-2017)
Figure Africa Oncology Injection Drug Sales Market Share by Type (2012-2017)
Figure Africa Oncology Injection Drug Sales Market Share by Type in 2016
Table Africa Oncology Injection Drug Sales (K Units) by Application (2012-2017)
Table Africa Oncology Injection Drug Sales Market Share by Application (2012-2017)
Figure Africa Oncology Injection Drug Sales Market Share by Application (2012-2017)
Table Africa Oncology Injection Drug Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oncology Injection Drug Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Injection Drug Sales Market Share by Countries (2012-2017)
Figure Africa Oncology Injection Drug Sales Market Share by Countries in 2016
Table Africa Oncology Injection Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Injection Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Oncology Injection Drug Revenue Market Share by Countries in 2016
Figure South Africa Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Table Taj Oncology Oncology Injection Drug Basic Information List
Table Taj Oncology Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Taj Oncology Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Taj Oncology Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Taj Oncology Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table S.G. Biopharm Oncology Injection Drug Basic Information List
Table S.G. Biopharm Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure S.G. Biopharm Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure S.G. Biopharm Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure S.G. Biopharm Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table AdvaCare Oncology Injection Drug Basic Information List
Table AdvaCare Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AdvaCare Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure AdvaCare Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure AdvaCare Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Merrimack Oncology Injection Drug Basic Information List
Table Merrimack Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merrimack Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Merrimack Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Merrimack Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Celgene Oncology Injection Drug Basic Information List
Table Celgene Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Celgene Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Celgene Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Allos Therapeutics Oncology Injection Drug Basic Information List
Table Allos Therapeutics Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allos Therapeutics Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Allos Therapeutics Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Allos Therapeutics Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Ferring Pharmaceuticals Oncology Injection Drug Basic Information List
Table Ferring Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Pharmaceuticals Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Ferring Pharmaceuticals Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Ferring Pharmaceuticals Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Genzyme Oncology Injection Drug Basic Information List
Table Genzyme Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genzyme Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Genzyme Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Genzyme Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Oncology Injection Drug Basic Information List
Table Eli Lilly Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Praecis Pharmaceuticals Oncology Injection Drug Basic Information List
Table Praecis Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Praecis Pharmaceuticals Oncology Injection Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Praecis Pharmaceuticals Oncology Injection Drug Sales Market Share in EMEA (2012-2017)
Figure Praecis Pharmaceuticals Oncology Injection Drug Revenue Market Share in EMEA (2012-2017)
Table Millennium Pharmaceuticals Oncology Injection Drug Basic Information List
Table Debiopharm Oncology Injection Drug Basic Information List
Table Alza Oncology Injection Drug Basic Information List
Table CordenPharma Oncology Injection Drug Basic Information List
Table Pharmascience Oncology Injection Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Injection Drug
Figure Manufacturing Process Analysis of Oncology Injection Drug
Figure Oncology Injection Drug Industrial Chain Analysis
Table Raw Materials Sources of Oncology Injection Drug Major Manufacturers in 2016
Table Major Buyers of Oncology Injection Drug
Table Distributors/Traders List
Figure EMEA Oncology Injection Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Injection Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oncology Injection Drug Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oncology Injection Drug Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oncology Injection Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oncology Injection Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oncology Injection Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oncology Injection Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oncology Injection Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oncology Injection Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oncology Injection Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Injection Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oncology Injection Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oncology Injection Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oncology Injection Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Injection Drug Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oncology Injection Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oncology Injection Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oncology Injection Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oncology Injection Drug Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oncology Injection Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oncology Injection Drug Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oncology Injection Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *